M&A

CohBar Entered into Definitive Merger Agreement with Morphogenesis to Advance Late-Stage Oncology Candidates

CohBar Entered into Definitive Merger Agreement with Morphogenesis to Advance Late-Stage Oncology Candidates

Shots: CohBar shareholders will receive a dividend of 3.30 shares of CohBar common...

Ironwood to Acquire VectivBio for ~$1B

Ironwood to Acquire VectivBio for ~$1B

Shots: Ironwood will purchase all of VectivBio’s outstanding ordinary shares...

enGene to go Public via Forbion European Acquisition Corp. SPAC Merger for ~$135M

enGene to go Public via Forbion European Acquisition Corp. SPAC Merger for ~$135M

Shots: The business combination will deliver gross proceeds to enGene of ~$135M in...

Sobi to Acquire CTI BioPharma for ~$1.7B

Sobi to Acquire CTI BioPharma for ~$1.7B

Shots: Sobi will acquire CTI for $9.10/share of common stock in cash representing...

Magenta Therapeutics Entered into a Definitive Merger Agreement with Dianthus Therapeutics to Advance DNTH103 for Severe Autoimmune Diseases

Magenta Therapeutics Entered into a Definitive Merger Agreement with Dianthus Therapeutics to Advance DNTH103 for Severe Autoimmun...

Shots: The combined company will have ~$180M in cash or cash equivalents incl. ~$7...

Starton Therapeutics to go Public via Healthwell Acquisition Corp. I SPAC Merger for ~$374M

Starton Therapeutics to go Public via Healthwell Acquisition Corp. I SPAC Merger for ~$374M

Shots: The combined company will have a pro forma enterprise value of $339M &...

Image